摘要
糖尿病患者患阿尔茨海默病(AD)风险增高,两种疾病联系的潜在机制尚未阐明。胰岛素增敏剂及新型长效胰升血糖素样肽-1(GLP-1)类似物已用于临床,可改善糖尿病患者认知障碍。
Numerous studies have demonstrated that diabetic patients have an increased risk of developing Alzheimer's disease (AD). The potential mechanism in linking DM and AD is not fully elucidated. Insulin sensitizers and novel long-effect glucagon-like peptide -1 (GLP-1) analogues have been applied to clinic to alleviate the diabetes-rela'ted cognitive dysfunction.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2013年第9期859-860,共2页
Chinese Journal of Diabetes
基金
国家自然科学基金(31070638)
关键词
糖尿病
阿尔茨海默病
认知障碍
Diabetes mellitus AlzheimerJs disease(AD) Cognitive impairment